Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Evidence-Based Medicine Working Group.
Evidence-based medicine: a new approach to teaching the practice of medicine.
JAMA, 268 (1992), pp. 2.420-2.425
[2.]
R. Austrian, R.M. Douglas, G. Schiffman, A.M. Coetzee, H.J. Koornhof, S. Hayde-Smith, et al.
Prevention of pneumococcal pneumonía by vaccination.
Trans Assoc Am Phys, 89 (1976), pp. 247-257
[3.]
P. Smit, D. Oberholzer, S. Hayden-Smith, H.J. Koomhnof, M.R. Hilleman.
Protective effícacy of pneumococcal polysaccharide vaccines.
JAMA, 238 (1977), pp. 2.613-2.616
[4.]
M.S. Simberkoff, A.P. Cross, M. Al-lbrahim, A.K. Baltch, P.J. Geiseler, J. Nadler, et al.
Efficacy of pneumococcal vaccine in high risk patients. Results of a veterans administration cooperative study.
N Eng J Med, 315 (1986), pp. 1.318-1.327
[5.]
D.S. Fedson, E.D. Shapiro, F.M. LaForce, M.A. Mufson, D.M. Musher, J.S. Spika, et al.
The pneumococca) vaccine afler 15 years of use.
Another view. Arch Intern Med, 154 (1994), pp. 2.531-2.535
[6.]
J.V. Hirschamnn, B.A. Lipsky.
The pneumococcal vaccine afler 15 years of use.
Arch Intern Med, 154 (1994), pp. 373-377
[7.]
D.S. Fedson.
Influenza and pneumococcal vaccination of the eldery: newer vaccines and prospects for clinical benefits at the margin.
Prev Med, 23 (1994), pp. 751-755
[8.]
N. Fiebach, W. Beckett.
Prevention of respiratory infections in adults.
Arch ínter Med, 154 (1994), pp. 2.545-2.557
[9.]
J.C. Butler, R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, R.R. Fackiam.
Pneumococcal polysaccharide vaccine effícacy. An evaluation of current recommendations.
JAMA, 270 (1993), pp. 1.826-1.831
[10.]
Subdirección General de Prestaciones, Evaluación de Tecnologías Sanitarias.
Ministerio de Sanidad y Consumo. Informe sobre vacuna neumocócica.
Med Clin (Barc), 102 (1994), pp. 383-386
[11.]
P. Gardner, T. Eickhoff, G.A. Poland, P. Gross, M. Griffin, M. LaForce, et al.
Adult immunizations.
Ann Intern Med, 121 (1996), pp. 35-40
[12.]
USPHS/IDSA., Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency.
Ann Intern Med, 124 (1996), pp. 349-361
[13.]
G.R. Siber.
Pneumococcal diseases: prospects for a new generation of vaccines.
Science, 265 (1994), pp. 1.385-1.387
[14.]
J.H. Bates, E. Nardell.
Institutional control measures for tuberculosis in the era of multiple drug resistance.
Chest, 108 (1995), pp. 1.690-1.710
[15.]
T.F. Brewer, G.A. Colditz.
Bacille Calmette-Guerin vaccination for the prevention of tuberculosis in health care workers.
Clin Infect Dis, 20 (1995), pp. 136-142
[16.]
P.E.M. Fine.
Variation in protection by BCG: implications of and for heterologous immunity.
Lancet, 346 (1995), pp. 1.339-1.345
[17.]
G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wiison, E. Burdick, H.V. Fineberg, et al.
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.
JAMA, 271 (1994), pp. 698-702
[18.]
J.G. Wheeler, L.C. Rodrigues, V. Diwan.
Efficacy of BCG [carta].
JAMA, 272 (1994), pp. 765
[19.]
J.D. Cirillo, C.K. Stover, B.R. Bloom, W.R. Jacobs, R.G. Barletta.
Bacterial vaccine vectors and bacillus Calmette-Guerin.
Clin Infect Dis, 20 (1995), pp. 1.001-1.009
[20.]
A.S. Malin, D.B. Young.
Designing a vaccine for tuberculosis. Unravelling the tuberculosis genome can we build a better BCG?.
Br Med J, 312 (1996), pp. 1.495
[21.]
J. Puig Barbera, S. Márquez Calderón.
Efectividad de la vacunación antigripal en los ancianos.
Una revisión crítica de la bibliografía. Med Clin (Barc), 105 (1995), pp. 645-648
[22.]
P.A. Gross, Hermogene, A.W. s, H.S. Sacks, J. Lau, R.A. Levandowski.
The efficacy of influenza vaccine in elderly persons. A metaanalysis and review of the lilerature.
Ann Inter Med, 123 (1995), pp. 518-527
[23.]
K.L. Nichol, K.L. Maregolis, J. Wuorenma, T. Von Stemberg.
The efficacy and cost efectiveness of vacination against influenza among eldery persons living in community.
N Engl J Med, 331 (1994), pp. 778-784
[24.]
J.P. Mullooly, M.D. Bennett, M.C. Hornbrook, W.H. Barker, W.W. Williams, P.A. Patriarca, et al.
Influenza vaccination programs for elderly persons: cost effectiveness in a health maintenance organization.
Ann Inter Med, 121 (1994), pp. 947-952
[25.]
K.L. Nichol, A. Lind, K.L. Margolis, M. Murdoch, R. McFadden, M. Hauge, et al.
The effectiveness of vaccination against influenza in healthy working adulls.
N Engl J Med, 333 (1995), pp. 889-893
[26.]
K.L. Margolis, K.L. Nichol, G.A. Poland, R.E. Pluhar.
Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial.
JAMA, 264 (1990), pp. 1.139-1.141
[28.]
W.M. McDonnell, F.K. Askari.
DNA vaccines.
N Engl J Med, 334 (1996), pp. 42-45
[29.]
V. Ausina, M.J. Condom.
Vacunación antineumocócica: una llamada de atención.
Arch Bronconeumol, 23 (1987), pp. 57-59
Copyright © 1997. Sociedad Española de Neumología y Cirugía Torácica
